Company Intelligence

Recursion Pharmaceuticals

Recursion Pharmaceuticals provides enterprise-grade artificial intelligence solutions, delivering specialized Recursion Pharmaceuticals Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Headquarters
Salt Lake City, United States
Founded
2013
Status
Active
Products
1
Reports
8
Last reviewed
Aug 2026

Overview

What this company is, what it builds, and who it serves.

Recursion Pharmaceuticals is a Healthcare AI company based in Salt Lake City, United States, founded in 2013.

Salt Lake City TechBio company industrializing AI-driven drug discovery with clinical-stage assets including REC-4881.

Verified founder profile on Brel: Chris Gibson.

What it builds

Recursion Pharmaceuticals Platform

Why It Matters

Recursion Pharmaceuticals provides enterprise-grade artificial intelligence solutions, delivering specialized Recursion Pharmaceuticals Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.

Products

Products and platforms connected to this company.

  • Recursion OS Biotechnology

    Explore Recursion OS by Recursion Pharmaceuticals. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,...

    View product intelligence

Founders

People linked to this company in the Brel founder graph.

Ecosystem

How this company connects across the Brel AI intelligence graph.

Company

Recursion Pharmaceuticals

Industry

Industries served

  • Biotechnology

Products

Capabilities

Recursion's AI capability centers on learning from proprietary, relatable biological datasets produced through automated experimentation rather than relying solely on public omics…

Features

  • Recursion OS platform combining automated experimentation, proprietary biological and chemical datasets, and AI models to
  • automated experimentation
  • proprietary biological
  • chemical datasets
  • AI models to discover
  • advance clinical-stage drug candidates across oncology
  • rare disease
  • other therapeutic areas

Country

United States

Use cases

Official Resources

Official and developer links on file for this company.

Latest Developments

Verified developments and timeline notes on file.

  • November 20, 2024: Recursion completed its combination with Exscientia; Exscientia became a wholly owned subsidiary. Latest
  • Company founded 2013 · founded Source
  • Development 2013 · development Source

Frequently Asked Questions

What does Recursion Pharmaceuticals do?

Recursion Pharmaceuticals specializes in artificial intelligence, developing Recursion Pharmaceuticals Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.

Where is Recursion Pharmaceuticals based and when was it founded?

Recursion Pharmaceuticals is based in United States and was founded in 2013.

What are the main products offered by Recursion Pharmaceuticals?

The flagship platform from Recursion Pharmaceuticals is Recursion Pharmaceuticals Platform, delivered primarily through b2b saas and enterprise api licensing.

Who are the primary target users of Recursion Pharmaceuticals?

Recursion Pharmaceuticals primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.

Sources & Verification

How this profile is verified and where the information comes from.

Verified
Last reviewed Aug 2026

Request a correction if you represent this company or believe information is inaccurate.